Nepal has Received the First Round of Vaccine Against Covid-19 Under Covax Facility Today.
Nepal Among the first Countries in Asia to Receive COVID-19 Vaccines from COVAX Facility
Nepal received its first consignment of COVID-19 vaccine doses shipped through the COVAX Facility, a partnership between CEPI, Gavi, UNICEF and WHO, made possible through generous donor support from governments, international organizations, foundations and the private sector. The delivery of COVAX-procured vaccines to Nepal is part of a historic step towards ensuring equitable distribution of COVID-19 vaccines globally, in what will be the largest vaccine procurement and supply operation in history.
The goal of the COVAX Facility is to supply Nepal with enough doses to vaccinate 20% of the population depending on funding availability. Under the first COVAX allocation, the COVAX Facility will deliver 1.92 million vaccine doses to Nepal by the end of May 2021, in support of the Government of Nepal’s nation-wide vaccination campaign.
Today, the first COVAX shipment of 348,000 doses of AstraZeneca ‘Covishield’ vaccines manufactured by the Serum Institute of India (SII), together with 350,000 syringes and 3500 vaccine safety boxes arrived in Kathmandu before being distributed to provinces and municipalities across the country. COVAX-supported vaccines provide a critical contribution to the Government of Nepal’s National Deployment and Vaccination Plan (NDVP) target to vaccinate roughly 22 million people, among them refugees, migrant returnees and other migrant populations. With the generous contribution of the Government of India, Nepal was able to commence the vaccination campaign and to date, 429,705 people have been vaccinated.
The COVAX Facility is generously funded by partner governments, including the Governments of Australia, Finland, France, Germany, Japan, Korea, Norway, Qatar, Saudi Arabia, Switzerland, the United Kingdom, the United States and the European Union as well as foundations and corporations
The arrival of the COVAX supplied vaccines will boost Nepal’s vaccination efforts as it coincides with the launch of the second phase of the vaccination campaign which targets those who are most vulnerable to developing severe illness from COVID-19 including the elderly and people with comorbidities. The second phase will also target teachers, as part of the expanded group of frontline workers.
Ongoing public health measures to prevent the transmission of COVID-19 will continue to be critical alongside vaccination. This includes adhering to testing and quarantine measures, mask wearing, hand hygiene, and physical distancing of at least two meters.
Representatives of the COVAX technical and funding partners joined the Minister of Health and Population, His Excellency Hridayesh Tripathi, in welcoming the global COVAX contribution to Nepal’s COVID-19 vaccination efforts at Tribhuvan International Airport in Kathmandu.
Development partners congratulated Nepal for being among the first countries in the world to have launched COVID-19 vaccination efforts in January 2021. They reiterated their solidarity with Nepal, as exemplified by the arrival of the first COVAX vaccine contribution.
Nepal’s development partners are committed to working with Nepal through the pandemic recovery period to ensure that no one is left behind. Supporting the vaccination of everyone living in Nepal through COVAX will go a long way to restoring normalcy, preventing the loss of social and economic gains made and paving the way for socio-economic recovery.
- DDA Approved COVISHIELD COVID-19 Vaccine for Emergency Use Authorization in Nepal
- DDA has given Emergency use Authorization of Vero Cell vaccine in Nepal